SetPoint Medical

SetPoint Medical is developing a novel bioelectronic medicine therapy to treat patients with autoimmune diseases such as rheumatoid arthritis, Crohn's disease, and multiple sclerosis. The company has developed a proprietary and innovative bioelectronic medicine platform, which includes a microregulator programmed through an interface based on a unique prescription pad. This novel therapy has the potential to provide patients and healthcare providers with a safe and effective alternative to pharmaceuticals, while significantly reducing costs for payers compared to biologic therapies.